Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-4 (IL-4) pathway.

Ann Kelly-Welch1, Erica M Hanson, Achsah D Keegan

  • 1Program in Oncology, Marlene and Stewart Greenebaum Cancer Center and Department of Microbiology and Immunology, University of Maryland, Baltimore, USA.

Science'S STKE : Signal Transduction Knowledge Environment
|July 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing nanomedicine and immunometabolism to treat allergic disease.

Nanomedicine (London, England)·2026
Same author

Impact of antigen loading in tolerogenic nanoparticles to mitigate Th2-mediated allergic lung inflammation.

Drug delivery and translational research·2024
Same author

Plexin B1 controls Treg numbers, limits allergic airway inflammation, and regulates mucins.

Frontiers in immunology·2024
Same author

M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice.

mBio·2023
Same author

Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation.

Frontiers in immunology·2022
Same author

Mice Expressing Cosegregating Single Nucleotide Polymorphisms (D298G and N397I) in TLR4 Have Enhanced Responses to House Dust Mite Allergen.

Journal of immunology (Baltimore, Md. : 1950)·2022

Interleukin-4 (IL-4) is a cytokine involved in allergic responses. Research highlights distinct IL-4 signaling in cell lines versus primary cells, crucial for developing new allergy and asthma treatments.

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • Interleukin-4 (IL-4) is a key cytokine produced by T(H)2 helper T cells, mast cells, basophils, and eosinophils.
  • IL-4 mediates responses implicated in allergic conditions such as asthma.

Purpose of the Study:

  • To investigate and understand the differences in IL-4 signaling pathways between long-term cell lines and primary cells.
  • To provide insights for the development of novel therapeutic strategies targeting IL-4 signaling for allergy and asthma.

Main Methods:

  • Comparative analysis of IL-4 signaling.
  • Utilizing long-term cell lines and primary cells in experimental studies.

Main Results:

  • Identified significant differences in IL-4 signaling mechanisms between experimental systems (cell lines vs. primary cells).

Related Experiment Videos

Conclusions:

  • Understanding these signaling disparities is critical for advancing therapeutic interventions.
  • The findings support the ongoing development of targeted therapies for IL-4-mediated diseases like allergy and asthma.